Pulmonary metastasectomy from soft tissue sarcomas

Clinics

Volumn 65, Issue 9, 2010, Pages 871-876

  Sardenberg, Rodrigo Afonso da Silva ^a   de Figueiredo, Luiz Poli ^b   Haddad, Fábio José ^a   Gross, Jefferson Luiz ^a   Younes, Riad Naim ^a,c  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c HOSPITAL SÍRIO LIBANÊS   (Brazil)

Author keywords

Lung; Metastasectomy; Metastases; Prognostic factors; Soft tissue sarcomas

Indexed keywords

ARTICLE; CANCER STAGING; FEMALE; HUMAN; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SARCOMA; SOFT TISSUE TUMOR; THORACOTOMY;

FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SARCOMA; SOFT TISSUE NEOPLASMS; THORACOTOMY;

EID: 78249275261     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322010000900010     Document Type: Article

References (38)

1. Gadgell SM, Harlan LC, Zeruto CA, Osswald M, Schwartz AG. Patterns of care in population-based sample of soft tissue sarcoma patients in the United States. Cancer. 2009; 15:2744-54, doi: 10.1002/cncr.24307.
2. Gadd MA, Casper ES, Woodruff JM, McComarck PM, Brennan MF. Development and treatment of pulmonary metastases in adult patients with extremety soft tissue sarcoma. Ann Surg. 1993; 6: 705-12, doi: 10. 1097/00000658-199312000-00002.
3. Brennan MF, Casper ES, Harrison LB, Shiu MH, Gaynor J, Hadju SI. The role of multimodality therapy in soft tissue sarcoma. Ann Surg. 1991; 214:328-36, doi: 10.1097/00000658-199109000-00015.
4. Brennan MF. Management of extremity soft tissue sarcoma. A J Surg. 1989; 158:71-8, doi: 10.1016/0002-9610(89)90319-X.
5. Putman JB, Roth JA, Wesley MN, Johnston MR, Rosenberg SA. Analysis of prognostic factors in patients undergoing resection of pulmonary metastases from soft tissue sarcomas. J Thorac Cardiovasc Surg. 1984; 87:60-8.
6. Billingsley KG, Burt ME, Jara E. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg. 1999; 229:602-10, doi: 10.1097/00000658-199905000-00002.
7. Pastorino U, Buyse M, Frielder G. Long- term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997; 113:31-49.
8. Martini N, McComarck PM. Evolution of the surgical management of pulmonary metastases. Chest Surg Clin N Am. 1998; 8:13-27.
9. Pastorino U. History of the Surgical management of Pulmonary Metastases and Development of the International Registry. Semin Thorac Cardiovasc Surg. 2002; 14:18-28, doi: 10.1053/stcs.2002.32881.
10. Suzuki M, Iwata T, Ando S. Predictors of survival with pulmonary metastasectomy for osteosarcomas and soft tissue sarcomas. J Thorac Cardiovasc Surg. 2006; 47:603-08.
11. Roth JA, Putman JB, Wesley MN, Rosenberg S. Differing determinants of prognosis following resection of pulmonary metastases from osteogenic and soft tissue sarcoma patients. Cancer. 1985; 55:1361-6, doi: 10.1002/ 1097-0142(19850315)55:6,1361::AID-CNCR2820550633.3.0.CO; 2-F.
12. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000; 92: 205-16, doi: 10.1093/jnci/92.3.205.
13. Kaplan EL. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 77:457-81, doi: 10.2307/2281868.
14. Cox DR. Regression models and life tables. J R Stat Soc. 1972; 34:187-220.
15. Blackmon SH, Shah N, Roth JA, Correa AM, Vaporcian AA, et al. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg. 2009; 88:877-85, doi: 10.1016/j.athoracsur.2009.04.144.
16. Casper ES, Gaynor JJ, Harrison LB, Paniceck DM, Hadju SI, Brennan MF. Preoperative and postoperative adjuvant combination chemotherapy for adults with high grade sarcoma. Cancer. 1994; 73:1644-51, doi: 10.1002/ 1097-0142(19940315)73:6,1644::AID-CNCR2820730616.3.0.CO; 2-V.
17. Komdeur R, Hoekstra HJ, Van Den Berg E. Metastases in soft tissue sarcomas: prognostic criteria and treatment perspectives. Cancer Metastases Rev. 2002; 21:67-183.
18. Pastorino U, Valente M, Gasparini M, Azzarelli A, Santor A, Alloisio M, et al. Lung resection for metastatic sarcomas: total survival from primary treatment. J Surg Oncol. 1989; 40: 275-80, doi: 10.1002/jso.2930400414.
19. Pastorino U, Veronesi G, Landoni C, Leon M, Picchio M, Solli PG. Fluorodeoxiglicose positron emission tomography improves preoperative staging of respectable lung metastases. J Thorac Cardiovasc Surg. 2003; 126:1906-10, doi: 10.1016/S0022-5223(03)00211-3.
20. Ueda T, Uchida A, Kodama K, Doi O, Nakahara K, Fujii Y, Ono K. Agressive pulmonary metastasectomy for soft tissue sarcomas. Cancer. 1993; 72:1919-25, doi: 10.1002/1097-0142(19930915)72:6,1919::AIDCNCR2820720621.3.0. CO; 2-D.
21. Franco CEG, Algarra SM, Ezcurra AT, Guillen-Grima F, Mindan JP, Buxalleu U WT. Long-term results after resection for soft tissue sarcoma pulmonary metastases. Interac Cardiovasc Thorac Surg. 2009; 9:223-6, doi: 10.1510/icvts.2009.204818.
22. Smith R, Pak Y, Kraybill W, Kane JM. Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy. Eur J Surg Oncol. 2008; 10:1010-6.
23. Younes RN, Gross JL, Taira AM, Martins AAC, Neves GS. Surgical resection of lung metastases: results from 529 patients. Clinics. 2009; 64:535-41, doi: 10.1590/S1807-59322009000600008.
24. Stojadinovic A, Leung DH, Allen P, Lewis JJ, Jaques DP, Brennan MF. Primary adult soft tissue sarcoma: time- dependent influence of prognostic variables. J Clin Oncol. 2002; 20:4344-52, doi: 10.1200/JCO.2002.07.154.
25. Gadd MA, Casper ES, Woodruff JM, McComarrck PM, Brennan MF. Development and treatment of pulmonary metastases in adult patients with extremety soft tissue sarcoma. Ann Surg. 1993; 6: 705-12, doi: 10. 1097/00000658-199312000-00002.
26. Jablons D, Steinberg SM, Roth JA. Metastasectomy for soft tissue sarcoma. Further evidence for efficacy and prognostic indicators. J Thorac Surg. 1989; 97:695-705.
27. Younes RN, Haddad FJ, Ferreira F, Gross JL. Surgical removal of pulmonary metastases: a prospective study in 182 patients. Rev Assoc Med Bras. 1998; 44:218-25, doi: 10.1590/S0104-42301998000300010.
28. Girard P, Spaggiari L, Baldeyrou P. Should the number of pulmonary metastases influence the surgical decision? Eur J Cardiothorac Surg. 1997; 12:385-92, doi: 10.1016/S1010-7940(97)00203-0.
29. van Geel AN, Pastorino U, Jauch KW, Judson IR, van Coevorden F, Buesa JM, et al. Surgical treatment of lung metástases: the European Organization for the Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer. 1996; 77:675-82, doi: 10.1002/(SICI)1097-0142(19960215)77:4,675::AID-CNCR13.3.0.CO; 2-Y.
30. Casson AG, Putnam JB, Natarajan G. Efficacy of pulmonary metastasectomy for recurrent soft tissue sarcoma. J Surg Oncol. 1991; 47:1-4, doi: 10.1002/jso.2930470102.
31. Rehders A, Hosch SB, Scheunemann P, Stoecklein NH, Knoefel WT, Peiper M. Benefit of Surgical of Lung Metastases in Soft Tissue Sarcoma. Arch Surg. 2007; 142:70-5, doi: 10.1001/archsurg.142.1.70.
32. Matsuzaki Y, Shimizu T, Edagawa M, Hara M, Tomita M, et al. The law of 3:prognostic parameters for resected metastatic pulmonary tumors. Ann Thorac Cardiovasc Surg. 2003; 9:290-4.
33. Verazin GT, Warneke JA, Driscoll DL, Karakousis C, Petrelli NJ, Takita H. Resection of lung metastases from soft tissue sarcomas: a multivariate analyses. Arch Surg. 1992; 127:1407-11.
34. Porter GA, Cantor SB, Walsh GL, Rusch VW, Leung DH, DeJesus AY, et al. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers. J Thorac Cardiovasc Surg. 2004; 127: 1366-72, doi: 10.1016/j.jtcvs.2003.11.016.
35. Van Oosteron AT, Mourisden HT, Nielsen OS. Results of randomized studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first and second-line chemotherapy in advanced soft tissue sarcoma patients. Eur J Cancer. 2002; 38:2397-406, doi: 10.1016/S0959-8049(02)00491-4.
36. Liebl LS, Elson F, Quass A, Gawad KA, Izbicki JR. Value of repeat resection for survival in pulmonary metastases from soft tissue sarcomas. Anticanc Res. 2007; 27: 2897-902.
37. Weiser MR, Downey RJ, Leung DHY, Brennan M. Repeat resection of pulmonary metastases in patients with soft tissue sarcomas. J Am Coll Surg. 2000; 191:184-91, doi: 10.1016/S1072-7515(00)00306-9.
38. Cerfolio R, Bryant AS. Is palpation of the nonresected pulmonary lobe(s) required for patients with non-small cell lung cancer? A prospective study. J Thorac Cardiovasc Surg. 2008; 5: 317-92.